Premium
P4‐229: Effects of extended‐release memantine (28 mg/day) on cognitive domains in patients with moderate to severe Alzheimer's disease: Post hoc analysis of a randomized trial
Author(s) -
Tocco Michael,
Hendrix Suzanne,
Miller Michael,
Pejovic Vojislav,
Graham Stephen
Publication year - 2011
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2011.05.2254
Subject(s) - memantine , psychology , post hoc analysis , randomized controlled trial , population , repeated measures design , placebo , donepezil , verbal fluency test , clinical psychology , developmental psychology , audiology , cognition , neuropsychology , medicine , psychiatry , disease , dementia , statistics , alternative medicine , mathematics , environmental health , pathology